Diabetic neuropathies
Top Cited Papers
- 10 August 2000
- journal article
- review article
- Published by Springer Nature in Diabetologia
- Vol. 43 (8) , 957-973
- https://doi.org/10.1007/s001250051477
Abstract
Diabetic neuropathy is a common complication of diabetes that is often associated both with considerable morbidity and mortality. The epidemiology and natural course of diabetic neuropathy is clouded with uncertainty, largely due to confusion regarding the definition and measurement of this disorder. The recent resurgence of interest in the vascular hypothesis, oxidative stress, the neurotrophic hypothesis and the possibility of the role of autoimmunity have opened up new avenues of investigation for therapeutic intervention. Paralleling our increased understanding of the pathogenesis of diabetic neuropathy, there must be refinements in our ability to measure quantitatively the different types of defects that occur in this disorder, so that appropriate therapies can be targeted to specific fibre types. These tests must be validated and standardised to allow comparability between studies and a more meaningful interpretation of study results. Our ability to manage successfully the many different manifestations of diabetic neuropathy depends ultimately on our success in uncovering the pathogenic processes underlying this disorder.This publication has 24 references indexed in Scilit:
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyPublished by Elsevier ,2002
- Experimental diabetic neuropathy: an updateDiabetologia, 1999
- Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial InfarctionCirculation, 1999
- Diabetic Neuropathies: Features and MechanismsBrain Pathology, 1999
- Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes MellitusA Randomized Controlled TrialJAMA, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Uncommon early-onset neuropathy in diabetic patientsZeitschrift für Neurologie, 1998
- MexiletineDrugs, 1998
- AUTOIMMUNE DIABETIC NEUROPATHYNeurologic Clinics, 1997